Document Detail


Aluminium hydroxide in bile-salt diarrhoea.
MedLine Citation:
PMID:  72956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The treatment of choleraic diarrhoea remains a problem. Cholestyramine is effective but long-term treatment is often impracticable. In-vitro studies have shown that aluminium hydroxide has bile-acid-binding properties comparable with those of cholestyramine. The bile-acid-binding properties of aluminium hydroxide have now been investigated in vivo and applied to the treatment of patients with choleraic diarrhoea. Aluminium hydroxide increased the faecal bile-salt concentration of patients with a normal bowel habit whereas magnesium hydroxide had no effect. Eight patients with severe choleraic diarrhoea were treated with aluminium-hydroxide suspension: bowel motion became less frequent and daily faecal weight fell.
Authors:
A Sali; W R Murray; C MacKay
Related Documents :
6894136 - Changes in bile flow and composition induced by radiographic contrast materials.
18840136 - Sorafenib inhibits mapk-mediated proliferation in a barrett's esophageal adenocarcinoma...
2219116 - Elevation of individual serum bile acids on exposure to trichloroethylene or alpha-naph...
2446876 - Bile acids in peroxisomal disorders.
23494626 - Production of long-chain hydroxy fatty acids by microbial conversion.
15294076 - Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Lancet     Volume:  2     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1977 Nov 
Date Detail:
Created Date:  1978-01-27     Completed Date:  1978-01-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1051-3     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aluminum Hydroxide / therapeutic use*
Bile Acids and Salts / analysis,  metabolism*
Diarrhea / drug therapy*,  etiology
Drug Evaluation
Duodenal Ulcer / drug therapy
Feces / analysis
Humans
Magnesium Hydroxide / therapeutic use
Male
Middle Aged
Suspensions
Chemical
Reg. No./Substance:
0/Bile Acids and Salts; 0/Suspensions; 1309-42-8/Magnesium Hydroxide; 21645-51-2/Aluminum Hydroxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis.
Next Document:  Discontinuation of maintenance digoxin therapy in general practice.